Skip to content

Application of Optical Surface Imaging System (Catalyst) in Reducing Cardiac Radiotherapy Dose in Breast Cancer Patients

Application of Optical Surface Imaging System (Catalyst) in Reducing Cardiac Radiotherapy Dose in Breast Cancer Patients

Status
Recruiting
Phases
Early Phase 1
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2100044734
Enrollment
Unknown
Registered
2021-03-26
Start date
2021-04-01
Completion date
Unknown
Last updated
2021-10-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

breast cancer

Interventions

Application of Optical Surface Imaging System group:Nil

Sponsors

The First Affiliated Hospital of Dalian Medical University
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1.Female; 2.After radical mastectomy or breast-conserving surgery; 3.Aged older than 18 years and younger than 80 years; 4.ECOG score is less than 2 points; 5.It has radiotherapy indications.

Exclusion criteria

Exclusion criteria: 1.People with claustrophobia; 2.Patients who cannot be treated with the Catalyst system; 3.Suffer from heart disease.

Design outcomes

Primary

MeasureTime frame
Cardiac radiation dose;

Countries

China

Contacts

Public ContactWang Xiaojie

The First Affiliated Hospital of Dalian Medical University

wxj860408@163.com+86 18098876712

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026